London Stock Exchange (ALK )

Allergy Therapeutics plc is a Europe-based speciality pharmaceutical company, which focuses on the treatment and prevention of allergy. The Company is engaged in the development, manufacture, marketing and sale of a range of pharmaceutical vaccine products, designed for the immunological treatment of the allergic condition. The Company’s geographical segment includes Germany, Rest of Europe, North America and Asia. Its subsidiaries include Allergy Therapeutics (Holdings) Ltd, Allergy Therapeutics (UK) Ltd, Allergy Therapeutics Development Ltd, Bencard Allergie GmbH, Bencard Allergie (Austria) GmbH, Allergy Therapeutics Italia s.r.l. and Allergy Therapeutics Iberica S.L.


Copyright  2010